To drive clinical translation of cell and gene therapies worldwide.
To improve lives through safe and effective cell and gene therapies.
Established in 1992, ISCT is the global steward fostering cell and gene therapy translation to the clinic. With a network of leading clinicians, regulators, researchers, technologists and industry partners, ISCT members have a shared vision to
translate cell and gene therapies into safe and effective therapies to improve patients’ lives worldwide.
ISCT is the global leader focused on translational aspects of developing cell-based therapeutics, advancing scientific research
into innovative treatments for patients. ISCT provides a unique collaborative environment that addresses three key areas of clinical translation: Academia, Regulatory and Commercialization. Through long term strategic relationships with global
regulatory agencies, academic institutions and industry partners, ISCT leads the advancement of research into clinical adoption and standard of care.
Comprised of over 2300 cell therapy experts across five geographic regions and representation
from over 60 countries, ISCT members are part of a global community of peers, thought leaders and organizations invested in cell therapy translation. For more information about the organization, key initiatives and upcoming meetings, please
visit: www.isctglobal.org, @ISCTglobal.
Click the committee's below to learn more: